Global Parkinsons Disease Drug Market Insights and Forecast to 2028

Global Parkinsons Disease Drug Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Parkinsons Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market by Application
1.3.1 Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parkinsons Disease Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Parkinsons Disease Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Parkinsons Disease Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Parkinsons Disease Drug Sales by Region
2.4.1 Global Parkinsons Disease Drug Sales by Region (2017-2022)
2.4.2 Global Sales Parkinsons Disease Drug by Region (2023-2028)
2.5 Global Parkinsons Disease Drug Revenue by Region
2.5.1 Global Parkinsons Disease Drug Revenue by Region (2017-2022)
2.5.2 Global Parkinsons Disease Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Parkinsons Disease Drug Sales by Manufacturers
3.1.1 Global Top Parkinsons Disease Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parkinsons Disease Drug in 2021
3.2 Global Parkinsons Disease Drug Revenue by Manufacturers
3.2.1 Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Parkinsons Disease Drug Revenue in 2021
3.3 Global Parkinsons Disease Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Parkinsons Disease Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parkinsons Disease Drug Sales by Type
4.1.1 Global Parkinsons Disease Drug Historical Sales by Type (2017-2022)
4.1.2 Global Parkinsons Disease Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
4.2 Global Parkinsons Disease Drug Revenue by Type
4.2.1 Global Parkinsons Disease Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
4.3 Global Parkinsons Disease Drug Price by Type
4.3.1 Global Parkinsons Disease Drug Price by Type (2017-2022)
4.3.2 Global Parkinsons Disease Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Parkinsons Disease Drug Sales by Application
5.1.1 Global Parkinsons Disease Drug Historical Sales by Application (2017-2022)
5.1.2 Global Parkinsons Disease Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
5.2 Global Parkinsons Disease Drug Revenue by Application
5.2.1 Global Parkinsons Disease Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
5.3 Global Parkinsons Disease Drug Price by Application
5.3.1 Global Parkinsons Disease Drug Price by Application (2017-2022)
5.3.2 Global Parkinsons Disease Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parkinsons Disease Drug Market Size by Type
6.1.1 North America Parkinsons Disease Drug Sales by Type (2017-2028)
6.1.2 North America Parkinsons Disease Drug Revenue by Type (2017-2028)
6.2 North America Parkinsons Disease Drug Market Size by Application
6.2.1 North America Parkinsons Disease Drug Sales by Application (2017-2028)
6.2.2 North America Parkinsons Disease Drug Revenue by Application (2017-2028)
6.3 North America Parkinsons Disease Drug Market Size by Country
6.3.1 North America Parkinsons Disease Drug Sales by Country (2017-2028)
6.3.2 North America Parkinsons Disease Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Parkinsons Disease Drug Market Size by Type
7.1.1 Europe Parkinsons Disease Drug Sales by Type (2017-2028)
7.1.2 Europe Parkinsons Disease Drug Revenue by Type (2017-2028)
7.2 Europe Parkinsons Disease Drug Market Size by Application
7.2.1 Europe Parkinsons Disease Drug Sales by Application (2017-2028)
7.2.2 Europe Parkinsons Disease Drug Revenue by Application (2017-2028)
7.3 Europe Parkinsons Disease Drug Market Size by Country
7.3.1 Europe Parkinsons Disease Drug Sales by Country (2017-2028)
7.3.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parkinsons Disease Drug Market Size by Type
8.1.1 Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Parkinsons Disease Drug Market Size by Application
8.2.1 Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Parkinsons Disease Drug Market Size by Region
8.3.1 Asia Pacific Parkinsons Disease Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Parkinsons Disease Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Parkinsons Disease Drug Market Size by Type
9.1.1 Latin America Parkinsons Disease Drug Sales by Type (2017-2028)
9.1.2 Latin America Parkinsons Disease Drug Revenue by Type (2017-2028)
9.2 Latin America Parkinsons Disease Drug Market Size by Application
9.2.1 Latin America Parkinsons Disease Drug Sales by Application (2017-2028)
9.2.2 Latin America Parkinsons Disease Drug Revenue by Application (2017-2028)
9.3 Latin America Parkinsons Disease Drug Market Size by Country
9.3.1 Latin America Parkinsons Disease Drug Sales by Country (2017-2028)
9.3.2 Latin America Parkinsons Disease Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Parkinsons Disease Drug Market Size by Type
10.1.1 Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Parkinsons Disease Drug Market Size by Application
10.2.1 Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Parkinsons Disease Drug Market Size by Country
10.3.1 Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis AG Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 AbbVie
11.4.1 AbbVie Corporation Information
11.4.2 AbbVie Overview
11.4.3 AbbVie Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AbbVie Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Impax Laboratories
11.7.1 Impax Laboratories Corporation Information
11.7.2 Impax Laboratories Overview
11.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Impax Laboratories Recent Developments
11.8 Lundbeck
11.8.1 Lundbeck Corporation Information
11.8.2 Lundbeck Overview
11.8.3 Lundbeck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lundbeck Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Corporation Information
11.9.2 Sun Pharma Overview
11.9.3 Sun Pharma Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sun Pharma Recent Developments
11.10 Wockhardt
11.10.1 Wockhardt Corporation Information
11.10.2 Wockhardt Overview
11.10.3 Wockhardt Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wockhardt Recent Developments
11.11 UCB
11.11.1 UCB Corporation Information
11.11.2 UCB Overview
11.11.3 UCB Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 UCB Recent Developments
11.12 Bausch Health
11.12.1 Bausch Health Corporation Information
11.12.2 Bausch Health Overview
11.12.3 Bausch Health Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bausch Health Recent Developments
11.13 Acadia
11.13.1 Acadia Corporation Information
11.13.2 Acadia Overview
11.13.3 Acadia Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Acadia Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parkinsons Disease Drug Industry Chain Analysis
12.2 Parkinsons Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parkinsons Disease Drug Production Mode & Process
12.4 Parkinsons Disease Drug Sales and Marketing
12.4.1 Parkinsons Disease Drug Sales Channels
12.4.2 Parkinsons Disease Drug Distributors
12.5 Parkinsons Disease Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Parkinsons Disease Drug Industry Trends
13.2 Parkinsons Disease Drug Market Drivers
13.3 Parkinsons Disease Drug Market Challenges
13.4 Parkinsons Disease Drug Market Restraints
14 Key Findings in The Global Parkinsons Disease Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Carbidopa/Levodopa
Table 3. Major Manufacturers of Dopamine Receptor Agonists
Table 4. Major Manufacturers of MAO-Inhibitors
Table 5. Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Parkinsons Disease Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 8. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
Table 9. Global Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 10. Global Parkinsons Disease Drug Sales Market Share by Region (2023-2028)
Table 11. Global Parkinsons Disease Drug Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Parkinsons Disease Drug Revenue Market Share by Region (2017-2022)
Table 13. Global Parkinsons Disease Drug Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Parkinsons Disease Drug Revenue Market Share by Region (2023-2028)
Table 15. Global Parkinsons Disease Drug Sales by Manufacturers (2017-2022) & (K Doses)
Table 16. Global Parkinsons Disease Drug Sales Share by Manufacturers (2017-2022)
Table 17. Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Parkinsons Disease Drug Revenue Share by Manufacturers (2017-2022)
Table 19. Parkinsons Disease Drug Price by Manufacturers (2017-2022) &(USD/Dose)
Table 20. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Parkinsons Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2021)
Table 22. Parkinsons Disease Drug Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Parkinsons Disease Drug Product Offered
Table 24. Date of Manufacturers Enter into Parkinsons Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 27. Global Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 28. Global Parkinsons Disease Drug Sales Share by Type (2017-2022)
Table 29. Global Parkinsons Disease Drug Sales Share by Type (2023-2028)
Table 30. Global Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Parkinsons Disease Drug Revenue Share by Type (2017-2022)
Table 33. Global Parkinsons Disease Drug Revenue Share by Type (2023-2028)
Table 34. Parkinsons Disease Drug Price by Type (2017-2022) & (USD/Dose)
Table 35. Global Parkinsons Disease Drug Price Forecast by Type (2023-2028) & (USD/Dose)
Table 36. Global Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 37. Global Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 38. Global Parkinsons Disease Drug Sales Share by Application (2017-2022)
Table 39. Global Parkinsons Disease Drug Sales Share by Application (2023-2028)
Table 40. Global Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Parkinsons Disease Drug Revenue Share by Application (2017-2022)
Table 43. Global Parkinsons Disease Drug Revenue Share by Application (2023-2028)
Table 44. Parkinsons Disease Drug Price by Application (2017-2022) & (USD/Dose)
Table 45. Global Parkinsons Disease Drug Price Forecast by Application (2023-2028) & (USD/Dose)
Table 46. North America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 47. North America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 48. North America Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 51. North America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 52. North America Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 55. North America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 56. North America Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 59. Europe Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 60. Europe Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 63. Europe Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 64. Europe Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 67. Europe Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 68. Europe Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 71. Asia Pacific Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 72. Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 75. Asia Pacific Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 76. Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 79. Asia Pacific Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 80. Asia Pacific Parkinsons Disease Drug Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Parkinsons Disease Drug Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 83. Latin America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 84. Latin America Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 87. Latin America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 88. Latin America Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 91. Latin America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 92. Latin America Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 95. Middle East and Africa Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 96. Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 99. Middle East and Africa Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 100. Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 103. Middle East and Africa Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 104. Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 106. Teva Corporation Information
Table 107. Teva Description and Major Businesses
Table 108. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 109. Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Teva Recent Developments
Table 111. Novartis AG Corporation Information
Table 112. Novartis AG Description and Major Businesses
Table 113. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 114. Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Novartis AG Recent Developments
Table 116. GSK Corporation Information
Table 117. GSK Description and Major Businesses
Table 118. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 119. GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. GSK Recent Developments
Table 121. AbbVie Corporation Information
Table 122. AbbVie Description and Major Businesses
Table 123. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 124. AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. AbbVie Recent Developments
Table 126. Merck Corporation Information
Table 127. Merck Description and Major Businesses
Table 128. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 129. Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Merck Recent Developments
Table 131. Boehringer Ingelheim Corporation Information
Table 132. Boehringer Ingelheim Description and Major Businesses
Table 133. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 134. Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Boehringer Ingelheim Recent Developments
Table 136. Impax Laboratories Corporation Information
Table 137. Impax Laboratories Description and Major Businesses
Table 138. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 139. Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Impax Laboratories Recent Developments
Table 141. Lundbeck Corporation Information
Table 142. Lundbeck Description and Major Businesses
Table 143. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 144. Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Lundbeck Recent Developments
Table 146. Sun Pharma Corporation Information
Table 147. Sun Pharma Description and Major Businesses
Table 148. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 149. Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Sun Pharma Recent Developments
Table 151. Wockhardt Corporation Information
Table 152. Wockhardt Description and Major Businesses
Table 153. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 154. Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Wockhardt Recent Developments
Table 156. UCB Corporation Information
Table 157. UCB Description and Major Businesses
Table 158. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 159. UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. UCB Recent Developments
Table 161. Bausch Health Corporation Information
Table 162. Bausch Health Description and Major Businesses
Table 163. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 164. Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Bausch Health Recent Developments
Table 166. Acadia Corporation Information
Table 167. Acadia Description and Major Businesses
Table 168. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 169. Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Acadia Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Parkinsons Disease Drug Distributors List
Table 174. Parkinsons Disease Drug Customers List
Table 175. Parkinsons Disease Drug Market Trends
Table 176. Parkinsons Disease Drug Market Drivers
Table 177. Parkinsons Disease Drug Market Challenges
Table 178. Parkinsons Disease Drug Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinsons Disease Drug Product Picture
Figure 3. Global Parkinsons Disease Drug Market Share by Type in 2021 & 2028
Figure 3. Carbidopa/Levodopa Product Picture
Figure 4. Dopamine Receptor Agonists Product Picture
Figure 5. MAO-Inhibitors Product Picture
Figure 6. Global Parkinsons Disease Drug Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinics
Figure 9. Other
Figure 10. Parkinsons Disease Drug Report Years Considered
Figure 11. Global Parkinsons Disease Drug Sales 2017-2028 (K Doses)
Figure 12. Global Parkinsons Disease Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Parkinsons Disease Drug Revenue 2017-2028 (US$ Million)
Figure 14. Global Parkinsons Disease Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
Figure 16. Global Parkinsons Disease Drug Sales Market Share by Region (2023-2028)
Figure 17. North America Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 18. North America Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 20. Europe Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 22. Asia-Pacific Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 24. Latin America Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 26. Middle East & Africa Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Parkinsons Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Parkinsons Disease Drug in the World: Market Share by Parkinsons Disease Drug Revenue in 2021
Figure 29. Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 31. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 32. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 33. Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 34. North America Parkinsons Disease Drug Sales Market Share by

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs